Pharmabiz23m
US FDA accepts Ascendis’ sBLA of TransCon for review to treat adults with growth hormone deficiency
Ascendis Pharma A/S, a global pharma company applying its innovative TransCon technology platform to build a leading and fully integrated biopharma company focused on making a meaningful difference in ...
Pharmabiz1h
NIH funded study shows long-term exposure to air pollution linked to blood clots in veins that bring blood to the heart
A large study found that greater exposure to long-term air pollution was linked with increased risks for blood clots that can occur in deep veins, which, if untreated, can block blood flow and cause ...
Pharmabiz2h
AIIMS signs MoU with Wipro GE Healthcare to establish ‘AI Health Innovations Hub’ to advance precision health solutions for India & the world
AIIMS signs MoU with Wipro GE Healthcare to establish ‘AI Health Innovations Hub’ to advance precision health solutions for India & the world: Our Bureau, Mumbai Saturday, Dec ...
Pharmabiz2h
Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification
Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification: Basel Saturday, December 14, 2024, 15:00 Hrs [IST] Roche announced the CE certification of t ...
Pharmabiz2h
UP govt to provide one 100-bed, two 20-bed, small 8-bed hospitals at Prayagraj Mahakumbh-2025
The Uttar Pradesh government will provide one 100-bed, two 20-bed, small 8-bed hospital at Prayagraj Mahakumbh-2025 as a part ...
Pharmabiz3h
Vir Biotech gets US FDA breakthrough therapy designation & EMA PRIME designation for tobevibart, elebsiran to treat chronic hepatitis delta
Vir Biotechnology, Inc, a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and ...
Pharmabiz3h
AI, robotics and sustainability to propel more personalized healthcare ecosystem in 2025: Atul Kurani
The healthcare industry is on the brink of a paradigm shift, with groundbreaking technologies and evolving patient behaviours driving a transition toward a more personalized and sustainable care ...
Pharmabiz4h
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours: Berlin Saturday, December 14, 2024, 13:00 Hrs [IST] Bayer announced i ...
Pharmabiz5h
BeiGene enters global licensing agreement CSPC Zhongqi Pharmaceutical for MAT2A inhibitor for solid tumours
BeiGene, Ltd., a global oncology company that intends to change its name to BeOne Medicines Ltd., announced it has entered into a global licensing agreement with CSPC Zhongqi Pharmaceutical Technology ...
Pharmabiz7h
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness: Basel Saturday, December 14, 2024, 10:00 Hrs [IST] Roche announced that the ...
Pharmabiz9h
Indian pharma industry set to make a mark at Clinical Pharmacy Congress London 2025
Indian pharma industry set to make a mark at Clinical Pharmacy Congress London 2025: Shardul Nautiyal, Mumbai Saturday, December 14, 2024, 08:00 Hrs [IST] The Indian pharmaceutica ...
Pharmabiz9h
Pharmacy career immune to recession, economic downturns; offers diverse job avenues
Pharmacy career immune to recession, economic downturns; offers diverse job avenues: Nandita Vijayasimha, Bengaluru Saturday, December 14, 2024, 08:00 Hrs [IST] Pharmacy career is ...